Evvy is at the forefront of precision care for vaginal health, offering an innovative platform designed to empower women and people with vaginas with detailed insights and personalised solutions. The core of their offering is an at-home vaginal microbiome test, which utilises clinical, validated metagenomic next-generation sequencing (mNGS) to provide the most reliable and comprehensive answers from a single swab. This advanced testing goes beyond traditional methods, identifying a wide range of bacteria and fungi to offer a complete picture of the vaginal ecosystem.
Upon receiving test results, Evvy's platform ensures that all findings are reviewed by a clinician. This expert oversight leads to a custom plan of clear next steps, which may include evidence-based prescription treatments if eligible, or recommendations for over-the-counter products like probiotics and suppositories. The goal is to address specific concerns such as bacterial vaginosis, yeast infections, UTIs, fertility challenges, and symptoms related to peri/menopause with targeted interventions.
A key differentiator for Evvy is its emphasis on proactive tracking through an optional membership. This allows users to monitor how various treatments and lifestyle behaviours impact their microbiome over time, fostering a deeper understanding of their body and enabling more effective, long-term health management. By combining cutting-edge diagnostics with personalised clinical care and continuous tracking, Evvy aims to revolutionise how vaginal health is understood and managed, moving towards a more informed and empowered approach to women's health.